ArticleOncology letters2026

CRISPR/Cas9-mediated claudin-2 knockout in HCT116 cells reveals its key role in colorectal cancer progression.

Rana A Alghamdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.